OUTER RETINAL TUBULATION IN RETINAL DYSTROPHIES.

Retina

*Department of Surgery (Eye), School of Medicine and Dentistry, College of Health Sciences, University of Ghana, Accra, Ghana; and†Srimati Kanuri Santhamma Centre for Vitreo-Retinal diseases, LV Prasad Eye Institute, Hyderabad, India.

Published: March 2017

Background/purpose: To evaluate the occurrence and characteristics of outer retinal tubulation (ORT) in an Indian population with retinal dystrophies.

Methods: In this retrospective study, 309 eyes of 157 patients with retinal dystrophies including retinitis pigmentosa (RP, 183 eyes), Stargardt disease (STGD, 93 eyes) and Best disease (33 eyes) were reviewed. The demographic details, clinical data including visual acuity, treatment history and good quality spectral domain optical coherence tomography (SD-OCT) scans were collected. The characteristics of ORT including location, number, type, associated intraretinal fluid, disruption of outer retina and presence of other lesions were recorded.

Results: ORT was detected in 12 eyes of 8 patients (unilateral in 4 eyes). Their mean age was 42.5 ± 13.89 yrs. (range, 21-60 yrs.), the mean baseline best corrected visual acuity was 0.425 ± 0.7 LogMAR (Snellen equivalent 20/53) and the median follow up was 6 months. The frequency of ORT were; 6 out of 183 (3%) eyes in RP, 2 out of 93 (2%) eyes in STGD, and 4 out of 33 (12%) eyes with Best disease and this difference in frequency was found to be statistically significant (χ = 6.93, p = 0.03). The average number of ORT in each eye was 2.75 ± 2.0 and the mean height of ORT was 40.8 ± 15.4 μm. Three eyes had co-existing choroidal neovascularization. All eyes had tubular structures except one that had the branching type. The ORT in 2 eyes of one patient with Best disease who had 3 years follow up data was found to be stable over the entire period.

Conclusion: ORTs are present in patients with RP, STGD and Best disease with a higher frequency in Best disease.

Download full-text PDF

Source
http://dx.doi.org/10.1097/IAE.0000000000001220DOI Listing

Publication Analysis

Top Keywords

best disease
20
eyes
12
outer retinal
8
retinal tubulation
8
retinal dystrophies
8
183 eyes
8
eyes best
8
visual acuity
8
ort
7
disease
6

Similar Publications

The present study analyzed the impact of age on the causes of death (CODs) in patients with nasopharyngeal carcinoma (NPC) undergoing chemoradiotherapy (CRT) using machine learning approaches. A total of 2841 patients (1037 classified as older, ≥ 60 years and 1804 as younger, < 60 years) were enrolled. Variations in the CODs between the two age groups were analyzed before and after applying inverse probability of treatment weighting (IPTW).

View Article and Find Full Text PDF

Background/objectives: Sepsis-related acute kidney injury (SA-AKI) is a severe condition characterized by high mortality rates. The utility of the sCAR (secrum creatinine/albumin) and LAR (Lactate dehydrogenase/albumin) as diagnostic markers for persistent severe SA-AKI remains unclear.

Methods: We acquired training set data from the MIMIC-IV database and validation set data from the First Affiliated Hospital of Harbin Medical University.

View Article and Find Full Text PDF

Hypochlorous acid (HClO) is a well-known inflammatory signaling molecule, while lipid droplets (LDs) are dynamic organelles closely related to inflammation. Using organic small-molecule fluorescence imaging technology to target LDs for precise monitoring of HClO is one of the most effective methods for diagnosing inflammation-related diseases. A thorough investigation of how probes detect biological markers and the influencing factors can aid in the design of probe molecules, the selection of high-performance tools, and the accuracy of disease detection.

View Article and Find Full Text PDF

Background: SL-172154 is a hexameric fusion protein adjoining the extracellular domain of SIRPα to the extracellular domain of CD40L via an inert IgG-derived Fc domain. In preclinical studies, a murine equivalent SIRPα-Fc-CD40L fusion protein provided superior antitumor immunity in comparison to CD47- and CD40-targeted antibodies. A first-in-human phase I trial of SL-172154 was conducted in patients with platinum-resistant ovarian cancer.

View Article and Find Full Text PDF

Background: The increased use of chemicals leads to a continuous deposition of chemicals in the environment and to a continuous increase in exposure of the global and the European population. Comprehensive burden of disease analyses are however still missing for many countries.

Methods: Using the World Health Organization's Environmental Burden of Disease (EBD) approach and combining data from the European Human Biomonitoring (HBM) dashboard with disease and population data, we estimated the comprehensive attributable burden (AB) for the year 2021, in the best-case quantified by disability-adjusted life years (DALY).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!